Summary
Ninety-two insulin-dependent diabetics (aged 4–20 years, mean±SD: 13±4) with a duration of diabetes from 2 to 17 years (7±3) were transferred from Lente or NPH (5 × crystallised insulin) to Monotard insulin (highly purified insulin). Total serum immunoreactive insulin levels and concentrations of antibodies against insulin, porcine proinsulin, a-component and pancreatic polypeptide were determined prior to [I] and at a mean of 220 [II], 460 [III], 830 [IV], and 1170 [V] days after the change. All but two subjects had insulin antibodies (IgG) at the start, with a mean value of 2864 μU/ml. There was a significant fall in the mean insulin antibody level between [I] and [II] to 2165 μU/ml (p<10-7), followed by an increase between [II] and [III] whereafter a slight decrease was observed being significant between [III] and [IV], as well as between [IV] and [V] (p<0.05); some patients showed a constant fall over the entire period, while others showed fluctuations. Total serum insulin showed a similar pattern, with a mean value of 1141 μU/ml at [I] declining to 522 μU/ml at [V]. The percentage fall between [I] and [V] was greater (54%) than that in the insulin antibodies (30%). Antibodies against acomponent, proinsulin and pancreatic polypeptide were present in 96%, 72% and 41% of the patients respectively before the change in therapy. There was a decline in these antibodies between each sampling (p values between <10-3 and 10-8) and, at the end of the investigation antibodies against a-component were above the detection limit in only 4 patients, and none of the patients showed antibodies against proinsulin or pancreatic polypeptide. Thus, removal of the impurities, including the hormonal contaminants of insulin, leads to a slow fall in antibodies to insulin and a much faster disappearance of antibodies against acomponent, proinsulin and pancreatic polypeptide.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Berson SA, Yalow RS, Bauman A, Rothschild MA, Newerly K (1956) Insulin-I131 metabolism in human subjects: Demonstration of insulin binding globulin in the circulation of insulin treated subjects. J Clin Invest 35: 170–190
Deckert T (1964) Insulin antibodies. Thesis. Munksgaard, Copenhagen
Fankhauser S (1969) Neuere Aspekte der Insulintherapie. Schweiz Med Wochenschr 99: 414–420
Galloway JA, Bressler R (1978) Insulin treatment in diabetes. Med Clin North Am 62: 663–680
Schlichtkrull J, Brange J, Christiansen AaH, Hallund O, Heding LG, Jørgensen KH, Munkgaard Rasmussen S, Sørenssen E, Vølund A (1974) Monocomponent insulin and its clinical implications. Radioimmunoassay: Methodology and applications in physiology and in clinical studies. Horm Metab Res 5: 134–143
Bruni B, Gamba S, Regis G, Turco GL (1978) Proinsulin and a-component antibodies in diabetics after long-term monocomponent insulin treatment. Diabetologia 14: 165–169
Ortved Andersen O (1973) Antibodies to proinsulin in diabetic patients treated with porcine insulin preparations. Acta Endocrinol (Kbh) 73: 304–313
Kumar D, Miller LV (1973) Proinsulin-specific antibodies in human sera. Diabetes 22: 361–366
Kumar D, Miller LV (1973) The prevalence of proinsulin-specific antibodies in diabetic patients. Horm Metab Res 5: 1–3
Klaff LJ, Vinik AI, Berelowitz M, Jackson WPU (1978) Circulating antibodies in diabetics treated with conventional and purified insulins. S Afr Med J 54: 149–153
Bloom SR, West AM, Polak JM, Barnes AJ, Adrian TE (1978) Hormonal contaminants of insulin. Gut 19: 318–322
Bloom SR, Barnes AJ, Adrian TE, Polak JM (1979) Autoimmunity in diabetics induced by hormonal contaminants of insulin. Lancet I: 14–17
Heding LG (1972) Determination of total serum insulin (IRI) in insulin-treated diabetic patients. Diabetologia 8: 260–266
Christiansen AaH (1973) Radioimmunoelectrophoresis in the determination of insulin binding to IgG. Methodological studies. Horm Metab Res 5: 147–154
Schlichtkrull J (1974) Antigenicity of monocomponent insulins. Lancet II: 1260–1261
Bruni B, Bruni Bøcher K, Gamba S, Giolitti A, Rittatore R, Turco GL (1977) Long-term clinical trial with porcine monocomponent Lente insulin (Monotard). Panminerva Med 19: 1–8
Larsson Y, Häger A, Ludvigsson J (1977) Insulin antibodies and therapeutic control in juvenile diabetics after transfer to monocomponent insulin (MCI). Acta Endocrinol [Suppl 209] (Kbh) 85: 51
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Heding, L.G., Larsson, Y. & Ludvigsson, J. The immunogenicity of insulin preparation. Antibody levels before and after transfer to highly purified porcine insulin. Diabetologia 19, 511–515 (1980). https://doi.org/10.1007/BF00253177
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00253177